CSR Synopses following approval of a new medicine or a new indication for an approved medicine in the US or EU. We are making CSR synopses available to supplement the public information available to patients and healthcare providers about the results of our clinical trials and the evidence used to approve a new medicine or a new indication.
Testosterone Gel: Androgel
|S176.1.010||Hypogonadism||Phase 1||A Multiple Dose Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption after Administration of 5g Testosterone Gel 1.62% to the Upper Arms/Shoulders using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males|
No results found